“First results from the study are expected in the second half of 2026.”
We’re off to the races chaps. Household name, 107, fda approved. There’s nothing holding us back now
Ann: CUV recruits 200 patients in Phase III vitiligo trial CUV105, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.97 |
Change
0.140(1.09%) |
Mkt cap ! $650.6M | |||
| Open | High | Low | Value | Volume |
| $12.90 | $13.25 | $12.88 | $1.268M | 97.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $12.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.97 | 365 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |